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dynamics
Abstract
We have constructed a recombinant herpes simplex virus type 1 (HSV-1) that simultaneously encodes
selected structural proteins from all three virion compartments-capsid, tegument, and envelope-fused
with autofluorescent proteins. This triple-fluorescent recombinant, rHSV-RYC, was replication
competent, albeit with delayed kinetics, incorporated the fusion proteins into all three virion
compartments, and was comparable to wild-type HSV-1 at the ultrastructural level. The VP26 capsid
fusion protein (monomeric red fluorescent protein [mRFP]-VP26) was first observed throughout the
nucleus and later accumulated in viral replication compartments. In the course of infection, mRFP-VP26
formed small foci in the periphery of the replication compartments that expanded and coalesced over
time into much larger foci. The envelope glycoprotein H (gH) fusion protein (enhanced yellow
fluorescent protein [EYFP]-gH) was first observed accumulating in a vesicular pattern in the cytoplasm
and was then incorporated primarily into the nuclear membrane. The VP16 tegument fusion protein
(VP16-enhanced cyan fluorescent protein [ECFP]) was first observed in a diffuse nuclear pattern and
then accumulated in viral replication compartments. In addition, it also formed small foci in the
periphery of the replication compartments which, however, did not colocalize with the small
mRFP-VP26 foci. Later, VP16-ECFP was redistributed out of the nucleus into the cytoplasm, where it
accumulated in vesicular foci and in perinuclear clusters reminiscent of the Golgi apparatus. Late in
infection, mRFP-VP26, EYFP-gH, and VP16-ECFP were found colocalizing in dots at the plasma
membrane, possibly representing mature progeny virus. In summary, this study provides new insights
into the dynamics of compartmentalization and interaction among capsid, tegument, and envelope
proteins. Similar strategies can also be applied to assess other dynamic events in the virus life cycle,
such as entry and trafficking.
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We have constructed a recombinant herpes simplex virus type 1 (HSV-1) that simultaneously encodes
selected structural proteins from all three virion compartments—capsid, tegument, and envelope—fused with
autofluorescent proteins. This triple-fluorescent recombinant, rHSV-RYC, was replication competent, albeit
with delayed kinetics, incorporated the fusion proteins into all three virion compartments, and was comparable
to wild-type HSV-1 at the ultrastructural level. The VP26 capsid fusion protein (monomeric red fluorescent
protein [mRFP]-VP26) was first observed throughout the nucleus and later accumulated in viral replication
compartments. In the course of infection, mRFP-VP26 formed small foci in the periphery of the replication
compartments that expanded and coalesced over time into much larger foci. The envelope glycoprotein H (gH)
fusion protein (enhanced yellow fluorescent protein [EYFP]-gH) was first observed accumulating in a vesicular
pattern in the cytoplasm and was then incorporated primarily into the nuclear membrane. The VP16 tegument
fusion protein (VP16-enhanced cyan fluorescent protein [ECFP]) was first observed in a diffuse nuclear
pattern and then accumulated in viral replication compartments. In addition, it also formed small foci in the
periphery of the replication compartments which, however, did not colocalize with the small mRFP-VP26 foci.
Later, VP16-ECFP was redistributed out of the nucleus into the cytoplasm, where it accumulated in vesicular
foci and in perinuclear clusters reminiscent of the Golgi apparatus. Late in infection, mRFP-VP26, EYFP-gH,
and VP16-ECFP were found colocalizing in dots at the plasma membrane, possibly representing mature
progeny virus. In summary, this study provides new insights into the dynamics of compartmentalization and
interaction among capsid, tegument, and envelope proteins. Similar strategies can also be applied to assess
other dynamic events in the virus life cycle, such as entry and trafficking.
The herpes simplex virus type 1 (HSV-1) virion consists of
three different compartments, capsid, tegument, and envelope.
The icosahedral capsid has a diameter of 125 nm and contains
the virus genome, a double-stranded DNA of 152 kbp. The
structural basis of the capsid are the 162 capsomers, which
include 150 hexons and 12 pentons (47). The capsomers are
connected in groups of three by a complex formed with two
copies of VP23 and one copy of VP19c (47, 54, 68). The hexons
are composed of six molecules of the major capsid protein
VP5. Eleven of the 12 pentons are composed of five molecules
of VP5, while 1 of the 12, the so-called portal, is a cylindrical
structure of 12 molecules of UL6 (46). Also involved in capsid
assembly, but not physical components of the capsids, are the
scaffold polypeptides VP22a, VP21, and the serine protease,
VP24, which is required for capsid maturation (9, 26, 38, 51).
Six copies of VP26, a 12-kDa polypeptide encoded by the
UL35 gene, occupy the tips of each hexon and thus decorate
the surface of the capsid (42, 69). Although not essential for
virus replication in tissue culture, VP26 was demonstrated to
be important for infectious virus production in trigeminal gan-
glia (12). VP26 is a protein expressed later in the virus repli-
cation cycle after the onset of DNA replication and has been
demonstrated to have multiple phosphorylated forms (43).
VP26 has been shown to be recruited in an ATP-dependent
manner after pro-capsid formation (8). As it lacks a nuclear
localization signal (NLS), it must form complexes with NLS-
containing proteins, such as VP5 and VP22a, in order to spe-
cifically accumulate in the nucleus (52, 60).
The virus capsid is surrounded by an amorphous layer, the
so-called tegument. The tegument contains at least 15 virus-
encoded proteins in various copy numbers which play impor-
tant structural and functional roles during infection (32). One
major structural component of the tegument is VP16, a 54-kDa
protein encoded by the UL48 gene (63). Although VP16 is not
essential for viral DNA replication, its structural role in the
tegument is essential. Recombinants of HSV-1 that lack the
UL48 gene show impaired replication, a defect in DNA pack-
aging, and the absence of infectious virus progeny (63). VP16
is responsible for transcriptional regulation of immediate-early
(IE) genes and is also involved in the modulation of the activ-
ities of early and late virus genes (7, 48, 49). VP16 has been
shown to coimmunoprecipitate with virion host shutoff protein
(55), to cross-link into complexes with gB, gD, and gH (70),
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and to copurify with UL47 (67) and with VP22 (16). Due to its
involvement in linking capsid and future envelope-associated
tegument proteins during virion formation, VP16 is absolutely
required for assembly of infectious virus (63) and plays essen-
tial roles in viral maturation and egress (24, 44).
The tegument is surrounded by the viral envelope, which is
a lipid membrane of cellular origin that contains at least 11
different viral glycoproteins. The glycoproteins are the major
antigenic determinants for the host-specific recognition, and
they are involved in cell entry, cell-to-cell spread, and immune
evasion. Glycoprotein H, the product of the UL22 gene, is a
110-kDa protein which is essential for infectivity (14) and
membrane fusion, but not for receptor binding (22, 25). Gly-
coprotein H must be coexpressed with gL in order for both
proteins to be properly processed, folded, and transported to
the virion envelope as well as the infected cell surface (33). The
gH/gL complex plays essential roles in viral penetration, cell-
to-cell spread, and syncytium formation (53). Both glycopro-
teins are conserved among the herpesviruses, although some
differences regarding assembly, structure, and intracellular
transport of the heterocomplex exist between individual her-
pesviruses (27, 33, 34, 50). Only very recently was it shown that
the simultaneous deletion of gH and gB results in a severe
deficit in nuclear egress leading to the accumulation of virions
in the perinuclear space, whereas the deletion of gH or gB
alone did not lead to a significant defect (19). One strategy to
investigate mechanisms of viral infection, replication, and as-
sembly is the fusion of viral proteins with autofluorescent pro-
teins (reviewed in reference 5). Many of the HSV-1 proteins
have been shown to maintain their functional activity when
fused with foreign polypeptides. Among these, a green fluo-
rescent protein (GFP)-VP26 fusion was demonstrated to be
incorporated into intranuclear capsids and mature virions,
where it was capable of interacting with VP5 while retaining its
autofluorescence (13). GFP-VP26 retained its biological activ-
ity during the replication cycle, as the recombinant virus rep-
licated at a rate comparable to that of wild-type (wt) virus (13).
A recombinant HSV-1 that expressed VP16 fused to GFP
(VP16-GFP) also showed normal replication kinetics and in-
corporation of the fusion protein into the virion (35). Similarly,
fusion of enhanced yellow fluorescent protein (EYFP) with gH
did not markedly alter gH functions, as the recombinant virus
was replication competent and showed stable autofluorescence
(39). The EYFP-gH fusion protein formed a stable heterocom-
plex with gL and was incorporated into the virion envelope as
well as cellular membranes (39).
In this study, we have constructed a recombinant HSV-1 that
simultaneously encodes the VP26 capsid protein fused with
monomeric red fluorescent protein (mRFP), the VP16 tegu-
ment protein fused with enhanced cyan fluorescent protein
(ECFP), and the gH envelope glycoprotein fused with EYFP.
This triple-fluorescent recombinant HSV-1, rHSV-RYC, was
replication competent and incorporated the autofluorescent
fusion proteins into all three virion compartments. Confocal
laser scanning microscopy (CLSM) of living infected cells re-
vealed new insights into the organization and dynamics of
HSV-1 infection and into the interactions between HSV-1
virion proteins. To our knowledge this is the first report of the
construction and live analysis of a recombinant virus encoding
three different autofluorescent fusion proteins.
MATERIALS AND METHODS
Cell culture and virus. BHK, Vero, and Vero 2-2 cells (56) were maintained
in Dulbecco’s modified Eagle medium (DMEM) supplemented with 10% fetal
bovine serum (FBS). Penicillin G at 100 units/ml, 100 g/ml streptomycin, and
0.25 g/ml amphotericin B were added to all cell culture media. For culturing
Vero 2-2 cells, 500 g/ml G418 was included in addition.
HSV-1 strain F as well as the recombinant viruses were grown, and titers were
determined in Vero cells.
Construction of recombinant viruses. Recombinant HSV-1 encoding one
(rHSV-R or rHSV-48Y), two (rHSV-RYor rHSV-RC), or three (rHSV-RYC or
rHSV-RYC/2) different virion proteins fused with autofluorescent proteins were
generated by homologous recombination in Escherichia coli SW102 and galK
selection/counterselection (62) using a bacterial artificial chromosome (BAC)-
cloned HSV-1 strain F genome (pYEbac102; kindly provided by Y. Kawaguchi,
Tokyo Medical and Dental University, Japan) (59).
Electroporation and galK positive/negative selection. To prepare electrocom-
petent bacteria, 500 l of an overnight culture of E. coli SW102/YEbac102 was
diluted in 25 ml LB medium containing 12.5 g/ml chloramphenicol in a 50-ml
conical flask and grown at 32°C. When the optical density at 600 nm reached 0.6,
10 ml of the culture was transferred to another 50-ml conical flask and incubated
at 42°C in a shaking water bath. After exactly 15 min, the culture was briefly
cooled on ice, transferred into two 15-ml tubes, and pelleted for 5 min at 5,000
rpm and 0°C. The supernatant was removed, and the pellet was resuspended in
1 ml ice-cold H2O by gently swirling the tube on ice. Then, 9 ml of ice-cold H2O
was added, and the cells were pelleted again; this step was repeated once more.
After the second washing and centrifugation step, the supernatant was removed,
and the pellet (approximately 50 l) was kept on ice until electroporated with
PCR product (targeting cassettes). In a first step (galK selection), a PCR product
(see below) that contained the E. coli galK gene flanked by 50 nucleotides of
sequence homology to either side of the targeting locus on the virus genome
(VP26, gH, and VP16) (Fig. 1) was electroporated into 25 l of electrocompetent
E. coli SW102/YEbac102 cells in a 0.1-cm cuvette (Bio-Rad, Hercules, CA) at 25
F, 1.75 kV, and 200 . After electroporation, the bacteria were grown in 1 ml
LB medium for 1 h at 32°C and then washed twice with 1 M9 salts (37 mM
Na2HPO4, 22 mM KH2PO4, 19 mM NaCl) as follows: the culture was pelleted at
13,000 rpm for 15 s, resuspended in 1M9 salts, and pelleted again. The washing
step was repeated once more. After the second wash, the supernatant was
removed and the pellet was resuspended in 1 M9 salts before 100-l aliquots
of serial dilutions (1:10, 1:100, and 1:1,000) were plated on galactose minimal
medium plates (62) supplemented with 12.5 g/ml chloramphenicol to select
Gal recombinant colonies. After 2 to 3 days of incubation at 32°C, colonies
were picked and streaked on MacConkey galactose indicator plates to obtain
single bright pink/red Gal colonies. One or two of these colonies were picked
to prepare electrocompetent bacteria for the second recombination step, the
in-frame introduction of autofluorescent protein-coding sequences into VP26,
gH, or VP16 sequences and galK counterselection. For this, electrocompetent E.
coli SW102 cells containing the galK-modified YEbac102 were prepared as de-
scribed above and electroporated with PCR products (targeting cassettes; see
below) containing coding sequences of autofluorescent proteins flanked by the
same 50 nucleotides present on the galK PCR product that target the DNA to
homologous sequences in the virus genome (VP26, gH, and VP16). After elec-
troporation, the bacteria were recovered in 10 ml LB medium for 4.5 h at 32°C
and washed twice with 1 M9 salts, and serial dilutions were plated on minimal
medium plates containing glycerol as carbon source, leucine, biotin, and 2-deoxy-
galactose (DOG; Acros Organics, Geel, Belgium) for selection against galK (62).
After 3 days of incubation at 32°C, colonies were picked, and BAC DNA was
isolated and characterized by restriction endonuclease and Southern analysis.
PCR amplification and purification of targeting cassettes. Phusion polymer-
ase (Finnzymes, Espoo, Finland) and the following primers were used to amplify
the targeting cassettes: (i) mRFP-VP26 fusion, galK selection, ul35-galK-fw, 5-A
CAGCCCTCCCGACCGACACCCCCATATCGCTTCCCGACCTCCGGT
CCCG CCTGTTGACAATTAATCATCGGCA-3, and ul35-galK-rev, 5-CCAAGC
GCCCGGACGCTATCGGTGGTAACGGTGCTGGGGCGGTGAAATTGTCA
GCACTGTCCTGCTCCTT-3; mRFP-VP26 fusion, galK counterselection, ul35-rfp-
fw, 5-ACAGCCCTCCCGACCGACACCCCCATATCGCTTCCCGACCTCCG
GTCCCGATGGCCTCCTCCGAGGACGTC-3, and ul35-rfp-rev, 5-CCAAGCG
CCCGGACGCTATCGGTGGTAACGGTGCTGGGGCGGTGAAATTGGGC
GCCGGTGGAGTGGCGGCC-3; (ii) EYFP-gH fusion, galK selection, UL22-
galK-fw, 5-GTTATTATTTTGGGCGCTGCGTGGGGTCAGGTCCACGACTG
GACTGAGCAGCCTGTTGACAATTAATCATCGGCA-3, and UL22-galK-rev,
5-CGTGTCGCGCCAGTACATGCGGTCCATGCCCAGGCCATCCAAAAAC
CATGGTCAGCACTGTCCTGCTCCTT-3; EYFP-gH fusion, galK counterselec-
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tion, UL22-EYFP-fw, 5-GTTATTATTTTGGGCGCTGCGTGGGGTCAGGTC
CACGACTGGACTGAGCAGGTGAGCAAGGGCGAGGAGCTGTTC-3 and
UL22-EYFP-rev, 5-CGTGTCGCGCCAGTACATGCGGTCCATGCCCAGGC
CATCCAAAAACCATGGCTTGTACAGCTCGTCCATGCCGAG-3; (iii) VP16-
ECFP fusion, galK selection, UL48-galK-fw, 5-TTCGAGTTTGAGCAGATGTTT
ACCGATGCCCTTGGAATTGACGAGTACGGTCCTGTTGACAATTAATCAT
CGGCA-3, and UL48-galK-rev, 5-GGTGACGGGAGGGGAAAACCCAGACGG
GGGATGCGGGTCCGGTCGCGCCCCTCAGCACTGTCCTGCTCCTT-3; VP16-
ECFP/EYFP fusion, galK counterselection, UL48-ECFP-fw, 5-TTCGAGTTTGAG
CAGATGTTTACCGATGCCCTTGGAATTGACGAGTACGGTGTGAGCA
AGGGCGAGGAGCTGTTC-3, and UL48-ECFP-rev, 5-GGTGACGGGAGG
GGAAAACCCAGACGGGGGATGCGGGTCCGGTCGCGCCCCTTACTTG
TACAGCTCGTCCATGCC-3. Sequence portions shown in italics are homolo-
gous to the galK gene. The following plasmids (10 ng) were used as templates:
pgalK for all galK selection/targeting cassettes (obtained from S. Warming,
National Cancer Institute, Frederick, MD) (62), pcDNA-mRFP-N1 (obtained
from U. F. Greber, University of Zurich, Zurich, Switzerland) for the VP26-
mRFP targeting cassette, and pECFP-N1 and pEYFP-N1 for amplification of
VP16-ECFP/EYFP and gH-EYFP targeting cassettes, respectively. The PCR
conditions were as follows: 94°C for 15 s, 60°C for 30 s, and 72°C for 1 min, for
30 cycles. After completion of the reaction, DpnI (10 U; New England Biolabs,
Allschwil, Switzerland) was added for digestion of the template for 2 h. The
DpnI-digested reaction mix was run on a 1% agarose gel, and the PCR product
was purified using a QIAQuick PCR purification kit (Qiagen, Hombrechtikon,
Switzerland) followed by ethanol precipitation. The DNA was resuspended in 40
l H2O, and an aliquot of 2 to 5 l (10 to 30 ng) was used for electroporation.
Excision of BAC sequences and isolation of recombinant HSV-1. To excise the
BAC DNA backbone and isolate recombinant viruses, 1.2  106 Vero 2-2 cells
(56) per 6-cm tissue culture plate were cotransfected with 0.2 g of plasmid p116,
which expresses Cre recombinase with an NLS (kindly provided by K. Tobler,
University of Zurich, Zurich, Switzerland), and 2 g of CsCl gradient-purified
recombinant HSV-1 BAC DNA using Lipofectamine (Invitrogen). After 2 to 3
days of incubation at 37°C, the supernatant was harvested and plaque purified
twice, and the excision of the BAC sequences was verified by PCR.
Virus replication assays. For the determination of growth kinetics, Vero cells
were inoculated at a multiplicity of infection (MOI) of 0.1 or 5 PFU per cell.
After 2 h of incubation at 37°C, 5% CO2, the cultures were washed three times
with PBS and then incubated with DMEM containing 2% FBS. Samples (cell
culture medium and cells) were removed after 0, 12, 24, 36, and 48 h. The cell
culture medium was removed from the cells and serially diluted to determine the
titers on Vero cells. The titers of cell-associated virus were determined on Vero
cells inoculated with serial dilutions of supernatants of cells prepared by three
cycles of freezing and thawing, followed by centrifugation at 1,900  g.
Determination of particle/PFU ratios. To determine the particle counts, virus
stocks with known titers (PFU/ml) were mixed with 204-nm-diameter latex beads
(Agar Scientific, Essex, United Kingdom) of known concentration, adsorbed
onto 300-mesh parlodion- and carbon-coated copper electron microscope grids
for 5 min at room temperature (RT), briefly washed with H2O, and negatively
stained with 2% sodium phosphotungstate, pH 7.4, for 1 min at RT. Samples
were examined in a transmission electron microscope (CM12; Philips, Eind-
hoven, The Netherlands), and the relative numbers of virus particles and latex
beads were determined, which allowed us to calculate the absolute numbers of
virus particles in the virus stocks.
Purification of virions. Virions were purified from BHK or Vero cells infected
at an MOI of 0.1 PFU with either wt HSV-1, rHSV-RYC, or rHSV-RYC/2.
When the cytopathic effect (CPE) was complete, the cultures were frozen and
thawed three times, and cell debris was removed by centrifugation for 10 min at
2,600 g and 4°C. Virions were purified through 60%, 30%, and 10% sucrose (in
PBS) gradients in Beckman Ultra-Clear 25- by 89-mm centrifuge tubes, which
were centrifuged for 2 h at 28,000 rpm and 4°C using a Beckman SW28 rotor.
The interface between the 30% and 60% sucrose layers was collected, diluted in
PBS, and ultracentrifuged for 1 h at 25,000 rpm and 4°C. Following resuspension
of the pellet in Hanks’ buffered saline solution, the virion stocks were frozen in
a dry ice-ethanol bath and stored at 80°C.
Immunoprecipitation, SDS-PAGE, Western analysis, and silver staining.
Vero cells (4  105 cells per well in a 12-well plate) were mock infected or
infected with either wt HSV-1, rHSV-RY, rHSV-RYC, or rHSV-RYC/2 at an
MOI of 1 PFU. When CPE was almost complete (between 24 and 48 h postin-
fection [p.i.]), the cells were washed with cold PBS and prepared for immuno-
precipitation or directly lysed with sodium dodecyl sulfate (SDS) loading buffer,
boiled for 5 min, and analyzed by SDS-polyacrylamide gel electrophoresis (SDS-
PAGE) and Western blotting using the antibodies listed below. For immuno-
precipitation, the cells were lysed with 200 l of EBC170 lysis buffer (50 mM Tris
pH 8.0, 170 mM NaCl, 0.5% NP-40) supplemented with one tablet of protease
inhibitor cocktail (Complete, mini, EDTA-free; Roche Diagnostics, Rotkreuz,
Switzerland) per 10 ml. The cell extract was collected and immunoprecipitated
with the gH-specific monoclonal antibody (MAb) LP11 (kindly provided by A.
Minson and H. Browne, University of Cambridge, United Kingdom) (6) diluted
1:30 in EBC170. After 1 h at 4°C, complexes were allowed to attach to protein
A-Sepharose beads. After washing the beads four times with EBC170 buffer, the
LP11 MAb complexes were eluted from the beads by adding SDS loading buffer.
The samples were boiled for 5 min, and proteins were separated by SDS-PAGE
and transferred onto nylon membranes (Protran; Whatman, Bottmingen, Swit-
zerland). Nonspecific reactions were blocked by incubating the membranes for
1 h with PBS containing 5% skimmed milk and 0.3% Tween 20. Membranes were
then incubated for 1 h with antibodies against VP26 (rabbit polyclonal antibody
[PAb] diluted 1:1,000 in PBS, 0.3% Tween 20 [PBS-T]; kindly provided by A.
Helenius, ETH Zurich, Switzerland), VP16 (MAb LP1, diluted 1:500 in PBS-T;
FIG. 1. Construction of rHSV-RYC. (A) Representation of the
HSV-1 BAC (YEbac102) genome structure, showing the region con-
taining the UL35 gene. The galK expression cassette was inserted into
the UL35 gene through homologous recombination (HR) and selec-
tion for Gal recombinants (rHSVBAC35galK). GalK was then re-
placed by mRFP coding sequences by HR and counterselected for
Gal recombinants (rHSVBAC35R). The same procedure was used
for the fusion of EYFP with the UL22 gene on the rHSVBAC35R
genome (B) and for the fusion of ECFP with the UL48 gene on rHSV
BAC35R22Y (C). The BAC sequences were removed by the Cre/loxP
recombination system (Cre), resulting in the recombinants HSV-1
rHSV-R, rHSV-RY, and rHSV-RYC. TRL, terminal repeat of the
long segment; UL, unique long segment; IRL, internal repeat of the
long segment; IRS, internal repeat of the short segment; US, unique
short segment; TRS, terminal repeat of the short segment.
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kindly provided by A. Minson and H. Browne, University of Cambridge, United
Kingdom) (41), GFP (MAb JL-8BD, diluted 1:8,000 in PBS-T; Clontech, Saint-
Germain-en-Laye, France), ICP4 (MAb, diluted 1:10,000 in PBS-T; Advanced
Biotechnologies, Columbia, MD), ICP8 (MAb clone 10A3, diluted 1:10,000 in
PBS-T; Abcam, Cambridge, United Kingdom), and VP22 (rabbit PAb AGV031,
diluted 1:10,000 in PBS-T; kindly provided by G. Elliott, Marie Curie Research
Institute, Oxted, United Kingdom). After washing, the membranes were incu-
bated with rabbit anti-mouse immunoglobulin G (IgG)–horseradish peroxidase
(HRP) (1:10,000 in PBS-T; Sigma-Aldrich, Buchs, Switzerland) or goat anti-
rabbit IgG–HRP (1:10,000 in PBS-T; Sigma-Aldrich, Buchs, Switzerland). Target
proteins were visualized by enhanced chemiluminescence (ECL Western blotting
analysis system; GE Healthcare, Zurich, Switzerland) and autoradiography
(Lumi-film chemiluminescent detection film; Roche Diagnostics, Rotkreuz, Swit-
zerland). A molecular weight standard (BenchMark prestained ladder; GIBCO,
Invitrogen, Basel, Switzerland) was used to determine the sizes of the protein
bands. Silver staining of gels was performed using the Bio-Rad silver stain kit
(Bio-Rad, Hercules, CA) according to the manufacturer’s manual.
CLSM. CLSM was performed on a Leica TCS SP2 AOBS confocal laser
scanning microscope (Leica Microsystems, Wetzlar, Germany) equipped with an
incubation chamber (THE BOX; Live Imaging Services, Reinach, Switzerland),
a temperature control device (THE CUBE; Live Imaging Services, Reinach,
Switzerland), and a gas mixer (THE BRICK; Live Imaging Services, Reinach,
Switzerland). The settings for the individual fluorophores were as follows: 4,6-
diamidine-2-phenylindole (DAPI), excitation at 405 nm and recording at 415 to
480 nm; ECFP, excitation at 458 nm and recording at 468 to 510 nm; fluorescein
isothiocyanate (FITC), excitation at 488 nm and recording at 498 to 570 nm;
EYFP, excitation at 514 nm and recording at 520 to 550 nm; mRFP/Atto590/
Alexa Fluor 594 (AF594), excitation at 594 nm and recording at 604 to 700 nm.
In order to avoid channel overlap, blue and red channels were recorded simul-
taneously while the yellow/green channels were recorded separately. The images
shown in Fig. 7 and 8, below, were deconvolved with a blind deconvolution
algorithm using the Huygens Essential 2.6.0p1 software (Scientific Volume Im-
aging, Hilversum, The Netherlands). Image processing was done with Imaris
5.0.1 (Bitplane AG, Zurich, Switzerland) and Adobe Photoshop CS 8.0.1 soft-
ware. The detailed procedures were as follows.
(i) High-resolution CLSM of live or fixed, infected cells. Vero cells were
seeded on Lab-Tek four-well chambered coverglasses (Nalge Nunc Interna-
tional, Rochester, NY) at 105 cells/well. On the following day, the cells were
washed once with cold (4°C) DMEM and incubated for 15 min at 4°C, and the
DMEM was replaced with cold (4°C) virus inoculum at the MOIs described in
the figure legends. The viruses were then allowed to adsorb to the cells for 1 h
at 4°C with gentle shaking. Subsequently, the virus inoculum was replaced with
warm (37°C) Iscove’s modified Dulbecco’s medium (GIBCO, Invitrogen, Basel,
Switzerland) supplemented with 25 mM HEPES and 2% FBS, and the cells were
incubated at 37°C, 5% CO2. At the indicated times after infection (temperature
shift), live cells were observed by CLSM in a humidified atmosphere at 37°C,
5%CO2. Where mentioned in the text below, the cells were fixed with 3.7%
formaldehyde in PBS for 15 min at RT prior to microscopy.
(ii) Time-lapse CLSM of live, infected cells. Vero cells were seeded into
35-mm glass-bottom dishes (MatTek, Ashland, MA) at 5 105 cells/dish. On the
following day, the cells were infected with rHSV-RY or rHSV-RYC diluted in
DMEM at the MOIs described in the text below. The viruses were allowed to
adsorb for 2 h at 37°C, 5% CO2. The cells were then washed with PBS, overlaid
with Iscove’s modified Dulbecco’s medium supplemented with 25 mM HEPES
and 2% FBS, and incubated at 37°C, 5% CO2. At the indicated time, live cells
were observed by CLSM in a humid atmosphere at 37°C, 5% CO2. Images were
recorded at intervals of 15 to 25 min.
Immunofluorescence. Vero cells were seeded on round 12-mm coverglasses in
24-well plates at 105 cells/well. On the following day, the cells were washed with
PBS and infected with wt HSV-1 or rHSV-RY diluted in DMEM at the MOIs
described in the figure legends. The viruses were allowed to adsorb for 1 to 2 h
at 37°C, 5% CO2. The cells were then washed with PBS, overlaid with DMEM
supplemented with 2% FBS, and incubated at 37°C, 5% CO2. At the indicated
time points, the cells were washed once with cold PBS and fixed with 3.7%
formaldehyde in PBS for 15 min at RT, and the fixation was stopped with 0.1 M
glycine in PBS for 5 min at RT. Immunofluorescence staining, DAPI staining,
and embedding of cells were performed as described previously (29) except that
the cells were permeabilized with 0.2% Triton X-100 in PBS for 15 min at RT
and that 0.2 mg/ml human IgG (Sigma-Aldrich, Buchs, Switzerland) was in-
cluded in the blocking solution when cells were stained with antibodies of rabbit
origin. Primary antibodies were used at the following dilutions: anti-HSV-1 ICP8
MAb 7381 (kindly provided by R. D. Everett, MRC Virology Unit, Glasgow,
United Kingdom), 1:500 (see Fig. 6C, below) or 1:1,000 (see Fig. 6D, below);
anti-HSV-1 gH MAb LP11, 1:3; anti-HSV-1 VP16 MAb LP1, 1:3 (see Fig. 8A,
below) or 1:200 (see Fig. 8D, below); rabbit anti-HSV-1 VP26 PAb VP26/C
(kindly provided by P. Desai, Johns Hopkins University, Baltimore, MD) (12),
1:400. Secondary antibodies were used as follows: F(ab)2 fragment of goat
anti-rabbit IgG(HL)–AF594 (Molecular Probes, Invitrogen, Basel, Switzer-
land), 1:200; goat anti-rabbit IgG(HL)–FITC (Southern Biotechnology, Bir-
mingham, AL), 1:100; goat anti-mouse IgG(HL)–AF594 (Molecular Probes,
Invitrogen, Basel, Switzerland), 1:200; Fab fragment of goat anti-mouse
IgG(HL)–FITC (Jackson ImmunoResearch, West Grove, PA), 1:100.
FISH. Infection with wt HSV-1 and immunofluorescence staining for VP26
were performed as described above. Fluorescent in situ hybridization (FISH) was
performed as described previously (18) with the following modifications: (i) cells
were fixed with precooled methanol for 10 min at 20°C; (ii) immunofluores-
cence staining was performed before the hybridization step; (iii) fluorescent
labeling of BAC-cloned HSV-1 DNA (YEbac102) was performed with an
Atto590 nick translation labeling kit according to the manufacturer’s manual
(Jena Bioscience, Jena, Germany).
Electron microscopy. Vero cells were grown on sapphire disks for 2 days prior
to infection with rHSV-RYC. After 24 h, cells were fixed with 0.25% glutaral-
dehyde for 30 min and then frozen in a high-pressure freezer (HPM010; BAL-
TEC Inc., Balzers, Liechtenstein) as previously described (37). The sapphire
disks carrying the frozen cells were transferred into a freeze-substitution unit (FS
7500; Boeckeler Instruments, Tucson, AZ) precooled to 88°C for substitution
with acetone and subsequent fixation with 0.25% glutaraldehyde and 0.5%
osmium tetroxide at temperatures between 30°C and 2°C as previously de-
scribed in detail (64) and embedded in Epon at 4°C. Sections of 50 to 60 nm were
analyzed in a transmission electron microscope (CM12; Philips, Eindhoven, The
Netherlands) equipped with a slow-scan charge-coupled-device camera (Gatan,
Pleasanton, CA) at an acceleration voltage of 100 kV.
RESULTS
Construction of a recombinant HSV-1 encoding mRFP-
VP26, VP16-ECFP, and EYFP-gH fusion proteins. The goal of
this study was to construct and characterize a recombinant
HSV-1 that simultaneously encodes selected structural pro-
teins from all three virion compartments fused with autofluo-
rescent proteins, in particular, capsid protein VP26 fused with
mRFP, tegument protein VP16 fused with ECFP, and enve-
lope glycoprotein H fused with EYFP. This triple-fluorescent
recombinant HSV-1 was constructed via homologous recom-
bination in E. coli using a BAC-cloned HSV-1 strain F genome
(pYEbac102) (59) and the galK positive/negative selection
method (62) as described in Materials and Methods. Briefly, in
a first step, a DNA fragment containing the galK expression
cassette flanked by homology arms that target the cassette
between codons 1 and 5 of the VP26 coding sequences was
electroporated into E. coli SW102 cells that contained the
pYEbac102 HSV-1 BAC DNA. Gal-positive recombinant bac-
teria were selected on galactose minimal medium plates. BAC
DNA prepared from these clones was characterized by restric-
tion endonuclease analysis (not shown), and one clone
(rHSVBAC35galK) was selected for the second recombination
step. For the second step, the galK expression cassette was
replaced by electroporating a DNA fragment containing the
mRFP expression cassette, again flanked by the homology
arms that facilitate the in-frame insertion of mRFP coding
sequences between codons 1 and 5 of the VP26 coding se-
quences, into E. coli SW102/rHSVBAC35galK. After galK
counterselection with DOG, Gal-negative colonies were
picked, BAC DNA was prepared and characterized by restric-
tion endonuclease analysis (not shown), and one clone (rHSV
BAC35R; Fig. 1A) was selected for further manipulation. The
subsequent fusion of gH with EYFP (rHSVBAC35R22Y; Fig.
1B) and VP16 with ECFP (rHSVBAC35R22Y48C; Fig. 1C)
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was performed using the same galK positive/negative selection
procedure described above and in Materials and Methods. The
final recombinant, rHSVBAC35R22Y48C, contained codons 1
to 225 of mRFP fused to codons 5 to 108 of VP26, codons 2 to
239 of EYFP inserted between codons 6 and 9 of gH, and
codons 1 to 489 of VP16 fused to codons 2 to 239 of ECFP.
Two additional recombinant HSV-1 BACs were constructed
that contained either codons 1 to 489 of VP16 fused to codons
2 to 239 of EYFP (rHSVBAC48Y) or codons 1 to 225 of
mRFP fused to codons 5 to 108 of VP26 and codons 1 to 489
of VP16 fused to codons 2 to 239 of ECFP (rHSVBAC35R
48C). A second triple-fluorescent recombinant HSV BAC,
rHSVBAC35R22Y48C/2, was created by introducing codons 2
to 239 of EYFP between codons 6 and 9 of gH in rHSVBAC
35R48C. The two triple-fluorescent HSV BACs, rHSVBAC
35R22Y48C and rHSVBAC35R22Y48C/2, encode the same
fusion proteins, but these were inserted in different orders. To
confirm that the recombinations had occurred as expected,
BAC DNA was analyzed by restriction endonuclease digestion
and Southern blot analysis (not shown). Finally, to rescue re-
combinant viruses and release the virus genome from the BAC
backbone, recombinant HSV-1 BAC DNA was cotransfected
with a Cre recombinase-expressing plasmid, p116, into mam-
malian cells (Fig. 1). Progeny virus was harvested after 2 to 3
days and plaque purified twice, and the excision of the BAC
sequences was confirmed by PCR analysis (not shown). The
recombinant viruses constructed and used in this study were
designated as follows: rHSV-R (mRFP-VP26), rHSV-48Y
(VP16-EYFP), rHSV-RY (mRFP-VP26 and EYFP-gH),
rHSV-RC (mRFP-VP26 and VP16-ECFP), rHSV-RYC (mRFP-
VP26, EYFP-gH, and VP16-ECFP), and rHSV-RYC/2 (mRFP-
VP26, EYFP-gH, and VP16-ECFP). The two triple-fluorescent
recombinants, rHSV-RYC and rHSV-RYC/2, produced compa-
rable titers and showed identical patterns of fluorescence in in-
fected cells (not shown).
Synthesis of autofluorescent fusion proteins in infected
cells. To verify that the recombinant viruses expressed the fluo-
rescent fusion proteins, Vero cells were mock infected or infected
with either wt HSV-1, rHSV-RY, or rHSV-RYC at an MOI of 1
PFU per cell. When the CPE was approximately 90%, cells were
harvested and analyzed. The 90% CPE was reached approxi-
mately 24 h p.i. for the wt virus and 48 h p.i. for the recombinant
virus, consistent with delayed replication kinetics of the recombi-
nant viruses (see Fig. 3, below). Western blotting with a rabbit
anti-VP26 PAb (kindly provided by A. Helenius, ETH, Zurich,
Switzerland) detected the 12-kDa VP26 protein from wt HSV-1-
infected cell lysates. In the lysates of rHSV-RY- or rHSV-RYC-
infected cells, the 12-kDa VP26 was not detected but was re-
placed with a band of approximately 50 kDa, which corresponds
to the size expected for the mRFP-VP26 fusion protein (Fig. 2A).
FIG. 2. Expression of fluorescent fusion proteins in infected cells. Vero cells were mock infected (m) or infected with either wt HSV-1 (wt),
rHSV-RY (RY), rHSV-RYC (RYC), or rHSV-RYC/2 (RYC/2) at an MOI of 1 PFU and harvested when the CPE was approximately 90%. Cell
lysates were analyzed by SDS-PAGE followed by Western blotting with antibodies against VP26 (A), VP16 (B), GFP (C), ICP4 (F), and ICP8 (G).
For detection of gH and EYFP-gH, cell lysates were immunoprecipitated with a gH-specific antibody followed by SDS-PAGE and silver staining
(D) or Western blotting with a GFP-specific antibody (E). Arrows indicate the mRFP-VP26, VP16-ECFP, and EYFP-gH fusion proteins, as well
as the wt VP26, VP16, gH, ICP4, and ICP8 proteins. The arrowheads in panels D and E point to a band that likely represents the EYFP-gH
precursor. Sizes of molecular weight standards are indicated.
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The band intensity of the wt 12-kDa VP26 protein was consis-
tently weaker than that of the 50-kDa mRFP-VP26 fusion pro-
tein. The reason for this might be that the relatively small VP26
protein adsorbed less well to the nitrocellulose membrane than
the larger fusion protein.
Western blotting with the anti-VP16 MAb LP1 (41) detected
the VP16 protein in lysates of cells infected with either wt
HSV-1 or rHSV-RY. In rHSV-RYC-infected cell lysates, how-
ever, the native VP16 was replaced by a band of approximately
100 kDa, which was also detected by the GFP-specific MAb
JL-8BD (Fig. 2B and C). As the GFP-specific antibody reacts
not only with GFP and ECFP but also with EYFP, a band of
approximately 140 kDa was visible in both rHSV-RY- and
rHSV-RYC-infected cell lysates which represented the
EYFP-gH fusion protein (Fig. 2C, left panel). Of note is that
the levels of the EYFP-gH fusion protein appeared to be
higher in rHSV-RY- than in rHSV-RYC-infected cells. We
therefore compared the EYFP-gH expression level of rHSV-
RYC to that of the independently constructed triple-labeled
virus, rHSV-RYC/2, as well as to rHSV-RY. As shown in Fig.
2C (right panel), the ratios between EYFP-gH and VP16-
ECFP were comparable for both triple-labeled viruses. In ad-
dition, in this experiment, the total amounts of EYFP-gH ap-
peared similar for the double- and triple-labeled viruses. The
reason for the fairly low levels of EYFP-gH detected in some
experiments therefore appears to be due to variations in the
efficiency of infection between different experiments, rather
than due to an inherent inability of the triple-colored viruses to
express normal amounts of EYFP-gH.
To compare the expression levels of gH from wt HSV-1 and
those of EYFP-gH from the recombinant viruses, cell lysates
were immunoprecipitated with the gH-specific MAb LP11 (6),
which binds to a conformational epitope of gH, followed by
SDS-PAGE and silver staining of the gel (Fig. 2D). A band
corresponding to the molecular mass of gH (110 kDa) was
visible for wt HSV-1 but was replaced with bands correspond-
ing to the molecular mass of EYFP-gH (140 kDa) in the
samples of the recombinant viruses. The levels of gH appeared
to be higher for wt HSV-1 and for rHSV-RY than for rHSV-
RYC. To confirm expression of the EYFP-gH fusion protein,
lysates were first immunoprecipitated with the gH-specific
MAb LP11 and then analyzed by SDS-PAGE and Western
blotting. The GFP-specific antibody detected the approxi-
mately 140-kDa EYFP-gH fusion protein in both rHSV-RY-
and rHSV-RYC-infected cell lysates (Fig. 2E). Of note is that
the levels of EYFP-gH were similar in this setting. Interest-
ingly, in rHSV-RY-infected cell lysates but not in rHSV-RYC-
infected cell lysates, a slightly smaller band was also visible,
which likely represents the EYFP-gH precursor (30) (Fig. 2E).
The accumulation of the EYFP-gH precursor might be a con-
sequence of the higher total levels of EYFP-gH of rHSV-RY
resulting in incomplete processing of the precursor, while the
lower EYFP-gH levels expressed by rHSV-RYC may be com-
pletely processed into the mature form. The GFP-specific an-
tibody also detected the VP16-ECFP fusion protein in rHSV-
RYC-infected and LP11-immunoprecipitated cell lysates (Fig.
2E), which is consistent with an earlier finding that gH can
coimmunoprecipitate with VP16 (31). An alternative explana-
tion, however, could be that VP16-ECFP and EYFP-gH coim-
munoprecipitate because GFP-derived proteins can undergo
weak dimerization (57, 65, 66).
We also compared the accumulation of the HSV-1 IE pro-
tein ICP4 and the early protein ICP8 among wt HSV-1 and the
recombinants. While ICP4 (Fig. 2F) accumulated to compara-
ble levels in cells infected with either wt HSV-1, rHSV-RY, or
rHSV-RYC, the levels of ICP8 (Fig. 2G) were reduced in cells
infected with the recombinant viruses. In conclusion, these
results demonstrated that the fusion proteins mRFP-VP26,
VP16-ECFP, and EYFP-gH were expressed in infected cells
with ongoing compromised levels of gene expression.
Growth kinetics of autofluorescent recombinant HSV-1. We
assessed the growth properties of recombinants that expressed
the mRFP-VP26 fusion alone or coexpressed two or three of
the fusion proteins. In the first set of experiments, Vero cells
were infected at a low MOI (0.1 PFU) with either wt HSV-1,
rHSV-R, rHSV-48Y, rHSV-RY, rHSV-RC, or rHSV-RYC,
and cultures were harvested at 12, 24, 36, and 48 h p.i. as
described in Materials and Methods. Virus yields in both cell
culture supernatant (Fig. 3A) and cells (Fig. 3B) were titrated
separately (PFU/ml). The growth properties of the recombi-
nant viruses compared to wt HSV-1 can be summarized as
follows: (i) the kinetics of virus release was delayed for recom-
binants rHSV-RY and rHSV-RYC, while all the other recom-
binants showed kinetics similar to that of wt HSV-1 (Fig. 3A);
(ii) in the supernatant, the final titers of the recombinant
viruses were reduced 2.6-fold (rHSV48Y) to 40-fold (rHSV-
RYC) at 48 h p.i; (iii) in the cell pellet, the final titers of the
recombinant viruses were reduced 7.7-fold (rHSV-RY) to 62-
fold (rHSV-RC) at 48 h p.i. While it appeared that the fusion
of EYFP to gH contributed to the delayed kinetics of virion
release of rHSV-RY and rHSV-RYC (Fig. 3A), the contribu-
tion of the individual fusions to the reduced final titers was less
obvious; specifically, the fusion of EYFP to VP16 alone
(rHSV-48Y) had the weakest effect on the final titers, and all
other recombinants, whether single, double, or triple labeled,
showed similar final titers in the supernatants (Fig. 3A).
In a second set of experiments, we compared the growth
properties of rHSV-RYC and wt HSV-1 at a high MOI (5
PFU) (Fig. 3C and D). Under these conditions, the growth
deficit of the triple-labeled recombinant was less pronounced.
Although the delayed kinetics of virus production was still
observed, the final titers at 48 h p.i. differed only by a factor of
5.8 in the supernatant and a factor of 5.6 in the pellet. These
findings suggest that the growth deficit of rHSV-RYC can be
partially overcome by infection at high MOI, which obviates
the need for efficient cell-to-cell spread.
To further characterize the growth properties of the recom-
binant viruses, we determined the particle/PFU ratios of two
recombinants, rHSV-RY and rHSV-RYC, as well as wt
HSV-1. We observed particle/PFU ratios of 68  49 (mean 
standard deviation) for rHSV-RY, 26  19 for rHSV-RYC,
and 1.3  0.9 for wt HSV-1, indicating that the recombinant
viruses were on average 20- to 50-fold less infectious than the
wt virus, a finding which at least partially explains the reduced
titers in the recombinant virus stocks.
In summary, the recombinant viruses showed reduced titers
both in the supernatant as well as in the pellet, with more
pronounced reductions at low than at high MOI. While the
fusion of EYFP to gH seemed to contribute to a delay in the
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kinetics of virion release, there was no clear correlation be-
tween the number of tagged virion proteins and the reduction
in titer. Finally, the recombinant viruses did not seem to have
a specific deficit at the level of virion egress, since the differ-
ences between the wt virus and the recombinants were com-
parable in the supernatant and the pellet. The data rather
suggest that the kinetics of recombinant virus replication was
delayed.
Incorporation of autofluorescent fusion proteins into the
virion. To confirm that all three fusion proteins were incorpo-
rated into the virion, wt HSV-1 virions and rHSV-RYC virions
were prepared by sucrose gradient centrifugation and analyzed
for the presence of the recombinant proteins. Western blotting
with the VP26-specific PAb revealed the 12-kDa VP26 in wt
HSV-1 virions and the 50-kDa mRFP-VP26 fusion protein in
rHSV-RYC virons (Fig. 4A). Similar to the observations made
in Fig. 2A, the band intensity of the wt VP26 protein was
weaker than that of the mRFP-VP26 fusion protein. As pre-
viously mentioned, this difference might be due to different
efficiencies of adsorption to the nitrocellulose membrane, since
it is unlikely that the fusion protein is incorporated more effi-
ciently into the virions than the wt protein. Similar observa-
tions were also made in a previous report (45). In order to
obtain a visible band for wt VP26, a doubled amount of wt
virions was loaded for the blot shown in Fig. 4A. Western
blotting with the VP16-specific MAb revealed the presence of
VP16 in the wt virions and VP16-ECFP in the rHSV-RYC
virions, the amounts of which appeared comparable (Fig. 4B).
The VP16-ECFP fusion protein, but not wt VP16, could also
be detected with the GFP-specific MAb (Fig. 4C). As expected,
the anti-GFP MAb also detected the EYFP-gH fusion protein
(Fig. 4C). As noted in Fig. 2, the ratio of EYFP-gH to VP16-
ECFP was quite variable between individual experiments (Fig.
2C, compare left and right panels). To detect gH from wt
HSV-1 and EYFP-gH from rHSV-RYC, virion proteins were
immunoprecipitated with the gH-specific MAb LP11 followed
by SDS-PAGE and silver staining. The results shown in Fig. 4D
demonstrate the presence of gH in wt virions and EYFP-gH in
rHSV-RYC virions. Again, it appeared that the level of gH was
higher in the wt virus than in with the recombinant. As ex-
pected, immunoprecipitation of virion lysates with LP11 fol-
lowed by Western blotting with the anti-GFP MAb detected
the EYFP-gH fusion protein but not the wt gH (Fig. 4E). As
previously noted (Fig. 2E), VP16-ECFP coimmunoprecipi-
tated with EYFP-gH (Fig. 4E). Staining for the VP22 tegu-
ment protein confirmed that comparable amounts of virions
were loaded on the gels (Fig. 4F). Taken together, these results
demonstrate that all three fusion proteins, mRFP-VP26,
VP16-ECFP, and EYFP-gH, are indeed incorporated into the
virus particle, although the amounts of incorporated EYFP-gH
were lower than those of wt gH.
Dynamics of compartmentalization of mRFP-VP26, VP16-
ECFP, and EYFP-gH in infected cells. Next, we monitored the
localization of mRFP-VP26, VP16-ECFP, and EYFP-gH in
FIG. 3. Growth kinetics of recombinant HSV-1 and wt HSV-1. Vero cells were infected with MOIs of 0.1 (A and B) or 5 (C and D) PFU of
either a recombinant HSV-1 (rHSV-R, rHSV-RY rHSV-RYC, rHSV-RC, or rHSV-48Y) or wt HSV-1, and progeny virus was harvested from the
cell culture medium (A and C) or from the cells (B and D) at 0, 12, 24, 36, and 48 h p.i. Titers are expressed as PFU per ml. The titers represent
means from three experiments. Error bars represent standard deviations.
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infected cells. For this, Vero cells were plated onto chambered
coverglasses and infected with rHSV-RYC, and live cells were
examined by CLSM at various times after infection. In the first
hours postinfection, small fluorescent foci were detected on
the surface of the cells and within the cytoplasm (Fig. 5a to d).
Some foci show colocalizations of ECFP, EYFP, and mRFP
signals, suggesting that they represent intact virions from the
virus inoculum (Fig. 5a to d, insets). De novo protein synthesis
was first observed at 6 h p.i. for VP16-ECFP, which was found
diffusely in the nucleus with accumulation in very early viral
replication compartments (RCs) (Fig. 5e and h). At 8 h p.i.,
VP16-ECFP was present in mature nuclear RCs as well as in
the cytoplasm, where it was found in a diffuse pattern with
accumulation in some small perinuclear foci (Fig. 5i and l). At
this time, expression of EYFP-gH and mRFP-VP26 also be-
came apparent. In particular, EYFP-gH was found diffusely in
the cytoplasm with some accumulation in a vesicular pattern
around the nucleus (Fig. 5j and l), while mRFP-VP26 was
found in small microfoci which were distributed throughout
the nucleus with accumulation in viral RCs (Fig. 5k and l).
These small microfoci displayed a high mobility within the
nucleus (not shown), reflecting active movement of nuclear
capsids (21). The localization of the VP26 and VP16 fusion
proteins to RCs was confirmed by staining rHSV-R- and
rHSV-48Y-infected cells for ICP8, a marker for RCs (Fig. 6C
and D). Between 10 and 16 h p.i., VP16-ECFP was predomi-
nantly found in the viral RCs as well as in small foci in their
periphery. In addition, the cytoplasmic VP16-ECFP accumu-
lation became more intense, with a pronounced recruitment of
VP16-ECFP to the plasma membrane, where it was found in a
dot-like pattern (Fig. 5m and p). At this stage, EYFP-gH was
still prominent in the cytoplasm but now strongly accumulated
in the nuclear membrane (Fig. 5n and p). Microfoci of mRFP-
VP26 were still observed in the nucleus, but in addition,
mRFP-VP26 was also observed in much larger foci which pref-
erentially formed in the periphery of the RCs, but it did not
colocalize with the small VP16-ECFP foci (Fig. 5o and p).
These large foci have previously been suggested to correspond
to sites of capsid assembly, so-called assemblons (13). Between
18 and 24 h p.i., two additional patterns became apparent.
FIG. 4. Incorporation of fluorescent proteins into virions. Purified wt HSV-1 (wt), rHSV-RY (RY), rHSV-RYC (RYC), and rHSV-RYC/2
(RYC/2) were analyzed by SDS-PAGE followed by Western blot analysis with antibodies specific for VP26 (A), VP16 (B), GFP (C), and VP22
(F). For detection of gH and EYFP-gH, virion proteins were immunoprecipitated with a gH-specific antibody and analyzed by SDS-PAGE
followed by silver staining (D) or Western blotting with a GFP-specific antibody (E). The corresponding fusion proteins mRFP-VP26, VP16-ECFP,
and EYFP-gH, as well as the wt VP26, VP16, gH, and VP22 proteins are indicated. Unspecific bands are marked by asterisks. Sizes of molecular
weight markers are shown.
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FIG. 5. High-resolution CLSM of living rHSV-RYC-infected cells. Vero cells were infected with an MOI of 18 PFU, and live cells were
observed by CLSM with settings specific for ECFP (VP16-ECFP fusion protein), EYFP (EYFP-gH fusion protein), and mRFP (mRFP-VP26
fusion protein). The thin gray lines in panels a to d mark the contours of the nucleus. The insets in panels a to d show a magnification of the sector
denoted by the white square. The filled arrowheads within the insets point to colocalizations of ECFP, EYFP, and mRFP signals. Arrows, early
RCs; filled triangle, VP16-ECFP foci in periphery of RCs; open triangles, large mRFP-VP26 and VP16-ECFP foci in periphery of nuclei; filled
diamonds, asymmetric, perinuclear accumulation of VP16-ECFP and mRFP-VP26. Images represent single z stacks of the cells.
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First, the majority of the VP16-ECFP was consistently re-
cruited out of the nucleus into the cytoplasm. Specifically, it
was found accumulating in an asymmetric, perinuclear pattern
reminiscent of the Golgi complex, where it often colocalized
with mRFP-VP26 and associated with EYFP-gH (Fig. 5q to t).
Second, in a subset of cells, VP16-ECFP was recruited into the
large mRFP-VP26 foci in the periphery of the nucleus, while
EYFP-gH remained in a pronounced perinuclear pattern (Fig.
FIG. 6. High-resolution CLSM of rHSV-RYC-infected cells and rHSV-R- and rHSV-48Y-infected cells stained for ICP8. (A) Vero cells were
infected with rHSV-RYC, and living cells were observed by CLSM as described for Fig. 5. The images show a high magnification of a protrusion
of the plasma membrane (top of picture). The arrows point to foci in which all three fusion proteins colocalize. The insets show magnifications
of these foci. (B) Vero cells were infected with rHSV-RYC, and fixed cells were observed by CLSM as described for panel A. (C) Vero cells were
infected with rHSV-R at an MOI of 10 PFU, fixed at 12 h p.i., and stained with the anti-ICP8 MAb 7381 and a FITC-conjugated secondary
antibody, as well as DAPI. The cells were observed by CLSM with settings specific for DAPI, FITC (ICP8), and mRFP (mRFP-VP26 fusion
protein). (D) Vero cells were infected with rHSV-48Y at an MOI of 10 PFU and stained as described for panel C, except that an AF594-conjugated
secondary antibody was used. The cells were observed by CLSM with settings specific for DAPI, EYFP (VP16-EYFP fusion protein), and AF594
(ICP8). Images in panels A to D represent single z stacks of the cells.
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5u to x). Finally, at these late time points, the dot-like accu-
mulations of VP16-ECFP at the plasma membrane consis-
tently colocalized with EYFP-gH and mRFP-VP26 (Fig. 5q to
t), suggesting that they reflect the accumulation of progeny
virus at the plasma membrane. This possibility was further
investigated by high-magnification CLSM of the plasma mem-
brane, which, as previously described, often formed pro-
nounced plasma membrane protrusions (35) (Fig. 6A and B).
On such plasma membrane protrusions, we observed a very
strong association of VP16-ECFP and mRFP-VP26 (Fig. 6A,
panel d) as well as a somewhat looser association of EYFP-gH
with mRFP-VP26 and VP16-ECFP (Fig. 6A, panels e and f).
The looser association of EYFP-gH with mRFP-VP26 and
VP16-ECFP is probably due to the fact that we observed living
cells and that while the ECFP and the mRFP channels were
recorded simultaneously, the EYFP channel was recorded sep-
arately, thus explaining the observed differences in the degree
of colocalization. Indeed, the association between the three
signals was more pronounced in fixed cells (Fig. 6B). These
observations, together with the fact that the number of dots
increased in the course of infection, support the hypothesis
that the dot-like accumulation of virion proteins of three dif-
ferent compartments at the plasma membrane might corre-
spond to accumulating virion progeny. Nevertheless, it cannot
be excluded that at least a subset of these foci also represent
virions from the inoculum which did not successfully enter the
cell and thus remained bound to the plasma membrane.
In order to obtain a more detailed picture of the subnuclear
FIG. 7. High-resolution CLSM of large VP26 foci. (A) Vero cells were infected with rHSV-RY at an MOI of 0.3 PFU, fixed at the indicated
times postinfection, stained with DAPI, and observed by CLSM with settings specific for DAPI, EYFP (EYFP-gH fusion protein), and mRFP
(mRFP-VP26 fusion protein). Images represent single z stacks of the cells. (B) Panels a and c show magnifications of the mRFP-VP26 foci marked
with the numbered arrows shown in panel A, while panels b and d show surpass views of three-dimensional reconstructions of the same foci.
(C) Vero cells were infected with wt HSV-1 at an MOI of 10 PFU, fixed at 12 h p.i., and stained with the rabbit anti-VP26 PAb VP26/C and a
FITC-conjugated secondary antibody. HSV-1 DNA was detected by FISH using an Atto590-labeled probe. Cells were observed by CLSM with
settings specific for DAPI, FITC (VP26), and Atto590 (HSV-1 DNA). Images represent single z stacks of the cells.
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distribution of the large mRFP-VP26 foci, we infected cells
with rHSV-RY, fixed them at 16 or 20 h p.i., and stained the
nuclei with DAPI. CLSM analysis revealed that, at such late
time points, the large mRFP-VP26 foci were often located at
the very periphery of the nuclei (Fig. 7A) and that the density
of mRFP-VP26 within these large foci was not homogenous
(Fig. 7B). Rather, mRFP-VP26 accumulated strongly at the
rim and displayed only a weak accumulation in the interior,
suggesting a hollow structure of these foci (Fig. 7B). In addi-
tion, we observed that while some of the VP26 structures were
still separated from the nuclear membrane by a thin layer of
condensed chromatin (Fig. 7B, panels a and b), others dis-
placed the chromatin to such an extent that they virtually
gained access to the nuclear membrane, which was visible by
virtue of EYFP-gH fluorescence (Fig. 7B, panels c and d). In
order to test if these large VP26 foci corresponded to an
accumulation of DNA-filled capsids, we codetected VP26 and
HSV-1 DNA in wt HSV-1-infected cells (Fig. 7C). While VP26
and HSV-1 DNA colocalized within the RCs, the large VP26
foci did not contain HSV-1 DNA. Assuming that DNA within
virions is accessible for FISH, these data suggest that the large
VP26 foci do not correspond to accumulations of DNA-filled
capsids.
To ascertain that the distribution of the fluorescent virion
proteins corresponded to that of the respective wt proteins, we
performed infections with wt HSV-1 and detected VP16, gH,
and VP26 by immunofluorescence. CLSM analysis of stained
cells revealed that the patterns for all three wt virion proteins
were very similar to those observed with the recombinant vi-
ruses (Fig. 8A to C). However, it has to be noted that the
accumulation of VP16 in large foci at the nuclear periphery
and their colocalization with VP26 was not observed in wt
HSV-1-infected cells stained with VP26- and VP16-specific
antibodies (Fig. 8D). This analysis also demonstrated that the
structure of the large VP26 foci was identical to that observed
with the mRFP-VP26 fusion protein (Fig. 8C, panel h). Inter-
estingly, the proportion of cells displaying such large VP26 foci
appeared to be somewhat smaller in wt HSV-1-infected cells
than in cells infected with the recombinant viruses.
Time-lapse CLSM of cells infected with either rHSV-RYC
or rHSV-RY allowed us to obtain a dynamic view of the in-
teraction between VP16, gH, and VP26 in the infected cells
(Fig. 9; see also movies S1 to S3 in the supplemental material).
Specifically, the image series demonstrated a very dynamic
compartmentalization of VP16-ECFP in the course of infec-
tion. While VP16-ECFP initially steadily accumulated in the
nuclear RCs and later in the small foci in the periphery of the
RCs, there was a very rapid and pronounced recruitment of
VP16-ECFP out of the nucleus into the cytoplasm and, in some
cells, into the large mRFP-VP26 foci at the periphery of the
nucleus in a late stage of infection. This redistribution was
fairly rapid and generally occurred within 1 to 2 h (Fig. 9A). In
addition, the time-lapse series revealed the progressive accu-
mulation of EYFP-gH at the nuclear membrane and in the
perinuclear cytoplasmic pattern (Fig. 9A and B). Finally, the
analysis demonstrated that the initially small foci of mRFP-
VP26 expanded and coalesced to form much larger foci, which
were pushed toward the periphery of the nucleus as infection
progressed (Fig. 9A and B).
Ultrastructural analysis of rHSV-RYC-infected cells. Elec-
tron microscopy revealed clear indications for normal matura-
tion of the triple-fluorescent recombinant HSV-1, rHSV-RYC,
with identical phenotypes to wt HSV-1 (Fig. 10). These phe-
notypes include formation of capsids with occasional crystal-
line-like accumulation within the nucleus (Fig. 10C), budding
of capsids at the inner nuclear membrane (Fig. 10B), budding
of capsids at Golgi membranes (Fig. 10D), virions within
vacuoles (Fig. 10E), and virions in the extracellular space
(Fig. 10F).
DISCUSSION
Autofluorescent proteins have been used extensively to
study many different biological processes, including the repli-
cation cycle of viruses (reviewed in reference 5). Recombinant
herpesviruses encoding individual virus proteins fused with
autofluorescent proteins have previously been constructed to
study several different aspects of the herpesvirus life cycle,
including trafficking, assembly, and maturation (11, 13, 15, 17,
20, 35, 39). Here, we report for the first time the construction
and time-lapse analysis of a recombinant HSV-1 that simulta-
neously encodes virus proteins from three different virion com-
partments, capsid (VP26), tegument (VP16), and envelope
(gH), fused with different autofluorescent proteins (mRFP,
ECFP, and EYFP, respectively).
Crucial to the construction of the triple-fluorescent recom-
binant HSV-1 was the availability of a BAC-cloned HSV-1
genome (59), which facilitated the easy manipulation of the
virus genome in bacteria. The combination of the HSV-1 BAC
with the possibility for both positive and negative selection in
bacteria provided by the galK system (62) allowed the serial
introduction of the three fusion genes into the virus genome.
The reconstitution of recombinant virus progeny and the
elimination of the BAC backbone were accomplished fol-
lowing cotransfection of the recombinant HSV-1 BAC DNA
with a Cre recombinase-expressing plasmid in mammalian
cells (Fig. 1).
Western analysis of infected cells demonstrated that all
three fusion proteins were synthesized (Fig. 2). Interestingly,
the triple-fluorescent recombinant HSV-1, rHSV-RYC, was
replication competent, although with delayed kinetics, and in-
corporated all three fusion proteins into the different virion
compartments. It appeared that the fusion of EYFP to gH was
responsible for a delay in the kinetics of virus release (Fig. 3).
This is consistent with a previous report describing the fusion
of EYFP to the N terminus of gH (39). Although the authors
of that study contended that the recombinant virus replicated
to titers comparable to those of wt HSV-1, it has to be noted
that the wt virus used in their study (strain 17 syn) reached
only a titer of 5.25  106 PFU/ml, which is rather low for a wt
virus. The fusion of autofluorescent proteins to VP16 and
VP26 also seemed to affect virus titers, although there were no
indications that fusion to the essential VP16 would have a
greater impact on viral replication fitness than fusion to the
nonessential VP26. In addition, the analysis did not support
the notion that the effects of the individual fusions were addi-
tive. Rather it appeared that the addition of at least one
autofluorescent fusion protein to a virus protein resulted in a
somewhat delayed kinetics of virus production (gH) or reduced
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final titers (VP16 or VP26). Electron microscopy analysis re-
vealed that the triple-fluorescent recombinant HSV-1 was
comparable to wt HSV-1 also at the ultrastructural level (Fig.
10). Moreover, CLSM of infected cells demonstrated that the
distribution and compartmentalization of the three autofluo-
rescent fusion proteins encoded by rHSV-RYC were compa-
rable to those observed with either wt HSV-1 or recombinants
of HSV-1 that encode autofluorescent proteins fused with
FIG. 8. Immunofluorescence staining for VP16, gH, and VP26 in wt HSV-1-infected cells. (A) Immunofluorescence staining for VP16. Vero cells
were infected with wt HSV-1 at an MOI of 10 PFU. At the indicated times postinfection, the cells were fixed and stained with the anti-VP16 MAb LP1
and an AF594-conjugated secondary antibody, as well as DAPI. The cells were then observed by CLSM with settings specific for DAPI and AF594. Filled
arrowhead, VP16 foci in the periphery of RCs. (B) Immunofluorescence staining for gH. Vero cells were infected and stained as described for panel A,
except that the anti-gH MAb LP11 was used. (C) Immunofluorescence staining for VP26. Vero cells were infected and stained as described for panel
A, except that the rabbit anti-VP26 PAb VP26/C was used. Panel h shows a magnification of the VP26 focus marked with an arrow. (D) Vero cells were
infected as described for panel A, fixed at 16 h p.i., and stained with DAPI, the anti-VP16 MAb LP1 (detected with an AF594-conjugated secondary
antibody), and the rabbit anti-VP26 PAb VP26/C (detected with a FITC-conjugated secondary antibody). The cells were then observed by CLSM with
settings specific for DAPI, AF594 (VP16, shown in green), and FITC (VP26, shown in red). Images in panels A to D represent single z stacks of the cells.
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VP26, gH, or VP16 individually (Fig. 5 to 8) (13, 35, 39).
Finally, the strong dot-like association of autofluorescent fu-
sion proteins of three different virion compartments, VP16-
ECFP, mRFP-VP26, and EYFP-gH, at plasma membrane pro-
trusions (Fig. 6A and B) supports the hypothesis that these
dots indeed are mature virions and that progeny virions incor-
porate sufficient amounts of the fluorescent fusion proteins to
allow their visualization, although this has to be confirmed on
the ultrastructural level. Nevertheless, it would be less convinc-
ing to draw such a conclusion with a recombinant HSV-1 that
encodes only one or two autofluorescent virion proteins.
The major advantage of our approach is the possibility for
simultaneously visualizing the distributions and interactions
between different virus proteins and virion compartments on
the single cell level. Moreover, our strategy allows study of the
dynamics of these events in live cells. For example, mRFP-
VP26 and VP16-ECFP colocalized within RCs in the nucleus
but, in addition, they both also formed foci in the periphery of
the RCs that did not colocalize (Fig. 5). In a previous report it
was hypothesized that the VP16 foci in the periphery of the
RCs may correspond to sites where capsids acquire VP16 (35).
Our experiments, however, suggest that this hypothesis is un-
likely. In the course of the infection, the mRFP-VP26 foci
expanded and coalesced to form larger foci that relocated to
the periphery of the nucleus. In the majority of the cells,
VP16-ECFP was redistributed from the nucleus to the cyto-
plasm late in infection, in a process that occurred very rapidly
(generally within 1 to 2 h). Of note is that in a subset of cells,
VP16-ECFP was, in addition, recruited into the large mRFP-
VP26 foci at the periphery of the nucleus (Fig. 5 and 9; see also
movies S1 to S3 in the supplemental material). This phenom-
enon was, however, not observed in wt HSV-1-infected cells
stained with VP16- and VP26-specific antibodies, in which
VP26, but not VP16, was consistently observed in the large foci
at the nuclear periphery (Fig. 8). In contrast, the colocalization
of VP26 and VP16 in the cytoplasm late in infection was
readily observed in both rHSV-RYC- and wt HSV-1-infected
cells (Fig. 5 and 8). There are two possible explanations for this
discrepancy: first, the fusion of ECFP to VP16 may have al-
tered some of its biological properties, leading to its recruit-
ment into the large mRFP-VP26 foci at the nuclear periphery.
Second, it is conceivable that VP16 and VP26 similarly colo-
calized in wt HSV-1-infected cells but that the VP16-specific
antibody employed did not detect VP16 when present in the
FIG. 9. Time-lapse CLSM of rHSV-RYC- and rHSV-RY-infected cells. Vero cells were infected with rHSV-RYC (A) or rHSV-RY (B) at
MOIs of 2 and 0.3, respectively. Cells that just started to accumulate fluorescent proteins were monitored by CLSM with settings specific for ECFP
(VP16-ECFP), EYFP (EYFP-gH), and mRFP (mRFP-VP26). Selected frames at the indicated intervals are shown. Images were processed with
Imaris software in the surpass view mode. Arrowheads denote the cells described in the text.
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large VP26 foci at the periphery of the nucleus, possibly be-
cause of an altered conformation of VP16 in these structures.
However, the very late appearance of this colocalization (18 to
24 h p.i.) suggests that it likely does not represent a crucial step
in the assembly and egress of progeny virus, since infectious
progeny are produced already at earlier time points (i.e., 12 h
p.i.) (Fig. 3). The accumulation of VP26 in large nuclear foci
was previously documented in cells infected with wt HSV-1
FIG. 10. Electron micrographs of Vero cells infected with rHSV-RYC after prefixation at 24 h p.i. followed by freezing and freeze-substitution.
(A) Low-power micrograph showing Golgi membranes, virions within a vacuole (arrow), and capsids (arrowheads) within the cytoplasm and
budding at Golgi membranes, respectively. (B) Virion within the perinuclear space of the nuclear envelope. (C) Accumulation of capsids in a
crystalline manner within the nucleus. (D) Budding capsid at Golgi membranes. (E) Virion within a concentric vacuole. (F) Virions in the
extracellular space. Bars, 500 nm (A and C) and 100 nm (B, D, and E).
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and stained with VP26-specific antibodies, as well as by expres-
sion of VP26 fused to GFP. The formation of nuclear VP26
foci was demonstrated to depend on the presence of VP5 and
VP22a and to occur in an ATP-dependent manner (8, 11, 13,
52). These VP26 foci were hypothesized to correspond to the
sites of capsid assembly, similar to the assemblons described by
Ward and coworkers, which contained the capsid proteins
ICP35, VP5, and VP19c and formed very late in infection at
the periphery of the nuclear RCs (13, 61). Interestingly, Ward
et al. (61) detected a partial colocalization between assemblons
and VP16 by staining with VP19c- and VP16-specific antibod-
ies. However, this partial colocalization clearly differs from the
almost perfect colocalization of VP16-ECFP and mRFP-VP26
in large foci at the nuclear periphery observed in our study
(Fig. 5). The ultrastructural correlate of this colocalization
remains to be determined. It is possible that the VP26 foci at
the nuclear periphery may represent the accumulation of dead-
end products, as previously suggested for assemblons (10, 36),
to which VP16 is recruited late in infection. This hypothesis is
further supported by the finding that these structures do not
contain HSV-1 DNA, indicating that they do not correspond to
accumulations of DNA-filled capsids (Fig. 7).
In summary, this study demonstrates the feasibility of the
construction of a recombinant HSV-1 simultaneously express-
ing autofluorescent proteins fused to VP16, VP26, and gH.
This study sheds light on the spatial and temporal organization
of HSV-1 infection at the single-cell level. Specifically, the
simultaneous fluorescence labeling of several virion compo-
nents allowed assessment of the interactions of the different
viral proteins in the course of the infection. This approach may
be used to address several open questions in HSV-1 biology,
for example, the spatial organization of capsid assembly and
maturation by fluorescent labeling of several components of
the pro-capsid and those of mature capsids. In addition, fluo-
rescently labeled virus proteins may be combined with systems
for the live visualization of viral DNA, as previously described
for several viruses, such as HSV-1, Epstein-Barr virus, and
adeno-associated virus (1, 23, 28, 29, 58), to specifically assess
the dynamics of the association of viral proteins with viral
DNA. Finally, the simultaneous fluorescent labeling of capsid,
tegument, and envelope components may prove useful for the
study of virus trafficking, for example, to assess and compare
the composition of virions transported in an anterograde ver-
sus retrograde direction within axons (2–4, 20, 40).
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